<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Precision Peptide Company Inc — News on 6ix</title>
<link>https://6ix.com/company/precision-peptide-company-inc</link>
<description>Latest news and press releases for Precision Peptide Company Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 05 May 2026 11:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/precision-peptide-company-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6968bbeedb30cb6ff2170.webp</url>
<title>Precision Peptide Company Inc</title>
<link>https://6ix.com/company/precision-peptide-company-inc</link>
</image>
<item>
<title>C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises</title>
<link>https://6ix.com/company/precision-peptide-company-inc/news/cdollar13-million-in-proceeds-received-by-the-precision-peptide-company-from-warrant-exercises</link>
<guid isPermaLink="true">https://6ix.com/company/precision-peptide-company-inc/news/cdollar13-million-in-proceeds-received-by-the-precision-peptide-company-from-warrant-exercises</guid>
<pubDate>Tue, 05 May 2026 11:30:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the receipt of approximately C$1.3 million from the exercise of outstanding warrants.The proceeds strengthen the Company's balance sheet and will be used to support the continued development and expansion of its Amino Innovations platform, including</description>
</item>
<item>
<title>The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt</title>
<link>https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-grants-rsus-and-stock-options-and-settles-debt</link>
<guid isPermaLink="true">https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-grants-rsus-and-stock-options-and-settles-debt</guid>
<pubDate>Mon, 04 May 2026 11:30:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan, as well as the issuance of common shares to settle outstanding indebtedness owed to a creditor of..</description>
</item>
<item>
<title>The Precision Peptide Company Announces Strategic Product Marketing Agreement</title>
<link>https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-announces-strategic-product-marketing-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-announces-strategic-product-marketing-agreement</guid>
<pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into a strategic product marketing agreement with Raw Creation, a UK-headquartered creative agency ("Raw Creation"), to provide certain social media management, creative content, editorial, paid advertising and related marketing services to the Company (the "Agreement").Pursuant to the Agreement, Raw Creation.</description>
</item>
<item>
<title>The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies</title>
<link>https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-applauds-fda-action-advancing-regulatory-clarity-for-peptide-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-applauds-fda-action-advancing-regulatory-clarity-for-peptide-therapies</guid>
<pubDate>Thu, 16 Apr 2026 11:30:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - April 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, commends the U.S. Food and Drug Administration (FDA) for its recent actions to advance regulatory clarity surrounding peptide substances.The FDA's decision to remove several peptides from Category 2 of bulk drug substances and refer them to further evaluation by..</description>
</item>
<item>
<title>The Precision Peptide Company Announces Public Relations and Consulting Services Agreement</title>
<link>https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-announces-public-relations-and-consulting-services-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-announces-public-relations-and-consulting-services-agreement</guid>
<pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreements with i) Think Ink Marketing Data and Email Services ("Think Ink") and ii) Ouimet Consulting Inc. ("Ouimet") to provide certain investor relations services to the Company.Think InkThe Company has entered into a public relations services agreement with Think Ink (the "Think Ink Agreement")....</description>
</item>
<item>
<title>The Precision Peptide Company Launches New Corporate Website and Comments on Evolving U.S. Policy in Support of Peptide-Based Therapies</title>
<link>https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-launches-new-corporate-website-and-comments-on-evolving-us-policy-in-support-of-peptide-based-therapies</link>
<guid isPermaLink="true">https://6ix.com/company/precision-peptide-company-inc/news/the-precision-peptide-company-launches-new-corporate-website-and-comments-on-evolving-us-policy-in-support-of-peptide-based-therapies</guid>
<pubDate>Tue, 07 Apr 2026 12:00:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, today launched it's new corporate website: www.precisionpeptidecompany.com. The website will offer regular updates regarding company developments.Additionally, the Company is encouraged by recent indications from U.S. Health and Human Services Secretary, Robert F..</description>
</item>
</channel>
</rss>